About LGS
- Like many rare conditions, Lennox-Gastaut Syndrome can be a complete mystery when you first hear about it. Explore this section to get a thorough understanding of LGS—including its causes, symptoms, diagnosis and treatment.
New to LGS
- A diagnosis of LGS is deeply unsettling and can leave you at a loss as to where to turn for help and guidance. We’re here for you. In this section you will find information, resources, and communities of support for the challenging road ahead.
For Families
- If a loved one is living with LGS, the entire family shares in the difficult journey. How can you keep them safe? Find appropriate medical care? Get the support you need? This section gives answers to these and other critical questions.
About Research
- Even as our understanding of LGS grows, there is so much more to learn. From research grants to conferences, from publications to voice of the patient family, this section provides avenues for furthering your knowledge and impact.
Get Involved
- Host a fundraiser. Volunteer at an event. Shop our LGS store. These are just some of the ways you can lend your personal support to our mission. Check out this section to get started.
Give Now
Search

Home / Team / Tim Benke, MD, PhD

Tim Benke, MD, PhD

Children's Hospital Colorado

Dr. Benke is the Research Director of the Neuroscience Institute which studies the mechanisms of early-life seizures to cause intellectual challenges and the role of CDKL5 on synaptic function. He initiated the multi-disciplinary Rett Clinic in 2011 at CHCO, where he is the Medical Director. This clinic is supported by NIH, the Rocky Mountain Rett Association (RMRA), and recognized and supported as an International Foundation for CDKL5 Research (IFCR) and RettSyndrome.org (RSO) Center of Excellence (COE).

Dr. Benke also leads the IFCR COE CDKL5 natural history initiative, is the site Primary Investigator for the NIH-funded Natural History Study of Rett, CDKL5, and FOXG1, and participates in clinical trials in RTT and CDKL5. One of his research goals is to understand the natural history of CDKL5 Deficiency Disorder, find better treatments, and, eventually, cures for this and other developmental encephalopathies.